Global RNAi for Therapeutic Market Research Report 2015-2025
- HEY3758304
- 82 Pages
- February 2020
- Healthcare
RNA interference (RNAi) is a biological process in which RNA molecules inhibit gene expression, typically by causing the destruction of specific mRNA molecules. Historically, it was known by other names, including co-suppression, post-transcriptional gene silencing (PTGS), and quelling. Only after these apparently unrelated processes were fully understood did it become clear that they all described the RNAi phenomenon. RNAi is now known as precise, efficient, stable and better than antisense technology for gene suppression.
The global RNAi for Therapeutic market will reach xxx Million USD in 2020 with CAGR xx% 2020-2025. The objective of report is to define, segment, and project the market on the basis of product type, application, and region, and to describe the content about the factors influencing market dynamics, policy, economic, technology and market entry etc.
Based on products type, the report describes major products type share of regional market. Products mentioned as follows:
siRNA
miRNA
shRNA
Leading vendors in the market are included based on profile, business performance etc. Vendors mentioned as follows:
Alnylam Pharmaceuticals
Arrowhead
Dicerna Pharmaceuticals
Mirna Therapeutics
Quark Pharmaceuticals
RXi Pharmaceuticals
miRagen Therapeutics
Gradalis
Sirnaomics
Based on Application, the report describes major application share of regional market. Application mentioned as follows:
Cancer
Cardiovascular
HBV
Others
Based on region, the report describes major regions market by products and application. Regions mentioned as follows:
Asia-Pacific
North America
Europe
South America
Middle East & Africa
1 Market Overview
1.1 Objectives of Research
1.1.1 Definition
Figure RNAi for Therapeutic Picture
1.1.2 Specifications
Table Product Specifications of RNAi for Therapeutic
1.2 Market Segment
1.2.1 by Type
Table Products Segment of RNAi for Therapeutic
Table Global RNAi for Therapeutic Market by Type, 2011-2022 (USD Million)
1.2.1.1 siRNA
Table siRNA Overview
1.2.1.2 miRNA
Table miRNA Overview
1.2.1.3 shRNA
Table shRNA Overview
1.2.2 by Application
Table Application Segment of RNAi for Therapeutic
Table Global RNAi for Therapeutic Market by Application, 2011-2022 (USD Million)
1.2.2.1 Cancer
Table Cancer Overview
1.2.2.2 Cardiovascular
Table Cardiovascular Overview
1.2.2.3 HBV
Table HBV Overview
1.2.2.4 Others
Table Others Overview
1.2.3 by Regions
Table Global RNAi for Therapeutic Market by Region, 2011-2022 (USD Million)
2 Industry Chain
2.1 Industry Chain Structure
Figure Industry Chain Structure of RNAi for Therapeutic
2.2 Upstream
Table Cost of RNAi for Therapeutic
Figure Manufacturing Process of RNAi for Therapeutic
2.3 Market
2.3.1 SWOT
Figure SWOT of RNAi for Therapeutic
2.3.2 Dynamics
Table Market Dynamics
3 Environmental Analysis
3.1 Policy
Table Policy of RNAi for Therapeutic
3.2 Economic
Table GDP of Major Countries
3.3 Technology
Table Technology of RNAi for Therapeutic
3.4 Market Entry
Table Market Entry of RNAi for Therapeutic
4 Market Segmentation by Type
4.1 Market Size
4.1.1 siRNA Market, 2013-2018
Figure siRNA Market Size and Growth, 2012-2018 (USD Million)
Figure siRNA Market Size and Growth, 2012-2018 (in Volume)
Table siRNA CAGR by Revenue and Volume, 2012-2018
4.1.2 miRNA Market, 2013-2018
Figure miRNA Market Size and Growth, 2012-2018 (USD Million)
Figure miRNA Market Size and Growth, 2012-2018 (in Volume)
Table miRNA CAGR by Revenue and Volume, 2012-2018
4.1.3 shRNA Market, 2013-2018
Figure shRNA Market Size and Growth, 2012-2018 (USD Million)
Figure shRNA Market Size and Growth, 2012-2018 (in Volume)
Table shRNA CAGR by Revenue and Volume, 2012-2018
4.2 Market Forecast
4.2.1 siRNA Market Forecast, 2020-2025
Figure siRNA Market Estimates and Forecasts, 2020-2025 (USD Million)
Figure siRNA Market Estimates and Forecasts, 2020-2025 (in Volume)
Table siRNA CAGR by Revenue and Volume, 2012-2024
4.2.2 miRNA Market Forecast, 2020-2025
Figure miRNA Market Estimates and Forecasts, 2020-2025 (USD Million)
Figure miRNA Market Estimates and Forecasts, 2020-2025 (in Volume)
Table miRNA CAGR by Revenue and Volume, 2012-2024
4.2.3 shRNA Market Forecast, 2020-2025
Figure shRNA Market Estimates and Forecasts, 2020-2025 (USD Million)
Figure shRNA Market Estimates and Forecasts, 2020-2025 (in Volume)
Table shRNA CAGR by Revenue and Volume, 2012-2024
5 Market Segmentation by Application
5.1 Market Size
5.1.1 Cancer Market, 2013-2018
Figure Cancer Market Size and Growth, 2012-2018 (USD Million)
Figure Market Size and Growth, 2012-2018 (in Volume)
Table Cancer CAGR by Revenue and Volume, 2012-2018
5.1.2 Cardiovascular Market, 2013-2018
Figure Cardiovascular Market Size and Growth, 2012-2018 (USD Million)
Figure Market Size and Growth, 2012-2018 (in Volume)
Table Cardiovascular CAGR by Revenue and Volume, 2012-2018
5.1.3 HBV Market, 2013-2018
Figure HBV Market Size and Growth, 2012-2018 (USD Million)
Figure Market Size and Growth, 2012-2018 (in Volume)
Table HBV CAGR by Revenue and Volume, 2012-2018
5.1.4 Others Market, 2013-2018
Figure Others Market Size and Growth, 2012-2018 (USD Million)
Figure Market Size and Growth, 2012-2018 (in Volume)
Table Others CAGR by Revenue and Volume, 2012-2018
5.2 Market Forecast
5.2.1 Cancer Market Forecast, 2020-2025
Figure Cancer Market Estimates and Forecasts, 2020-2025 (USD Million)
Figure Cancer Market Estimates and Forecasts, 2020-2025 (in Volume)
Table Cancer CAGR by Revenue and Volume, 2020-2025
5.2.2 Cardiovascular Market Forecast, 2020-2025
Figure Cardiovascular Market Estimates and Forecasts, 2020-2025 (USD Million)
Figure Cardiovascular Market Estimates and Forecasts, 2020-2025 (in Volume)
Table Cardiovascular CAGR by Revenue and Volume, 2020-2025
5.2.3 HBV Market Forecast, 2020-2025
Figure HBV Market Estimates and Forecasts, 2020-2025 (USD Million)
Figure HBV Market Estimates and Forecasts, 2020-2025 (in Volume)
Table HBV CAGR by Revenue and Volume, 2020-2025
5.2.4 Others Market Forecast, 2020-2025
Figure Others Market Estimates and Forecasts, 2020-2025 (USD Million)
Figure Others Market Estimates and Forecasts, 2020-2025 (in Volume)
Table Others CAGR by Revenue and Volume, 2020-2025
6 Market Segmentation by Region
6.1 Market Size
6.1.1 Asia-Pacific
6.1.1.1 Asia-Pacific Market, 2012-2018
Figure Asia-Pacific Market Size and Growth, 2012-2018 (USD Million)
Figure Asia-Pacific Market Size and Growth, 2012-2018 (in Volume)
Table Asia-Pacific CAGR by Revenue and Volume, 2012-2018
6.1.1.2 Asia-Pacific Market by Type
Figure Asia-Pacific Market Size by Type
Figure Asia-Pacific Market Share by Type
6.1.1.3 Asia-Pacific Market by Application
Figure Asia-Pacific Market Size by Application
Figure Asia-Pacific Market Share by Application
6.1.2 North America
6.1.2.1 North America Market, 2012-2018
Figure North America Market Size and Growth, 2012-2018 (USD Million)
Figure North America Market Size and Growth, 2012-2018 (in Volume)
Table North America CAGR by Revenue and Volume, 2012-2018
6.1.2.2 North America Market by Type
Figure North America Market Size by Type
Figure North America Market Share by Type
6.1.2.3 North America Market by Application
Figure North America Market Size by Application
Figure North America Market Share by Application
6.1.3 Europe
6.1.3.1 Europe Market, 2012-2018
Figure Europe Market Size and Growth, 2012-2018 (USD Million)
Figure Europe Market Size and Growth, 2012-2018 (in Volume)
Table Europe CAGR by Revenue and Volume, 2012-2018
6.1.3.2 Europe Market by Type
Figure Europe Market Size by Type
Figure Europe Market Share by Type
6.1.3.3 Europe Market by Application
Figure Europe Market Size by Application
Figure Europe Market Share by Application
6.1.4 South America
6.1.4.1 South America Market, 2012-2018
Figure South America Market Size and Growth, 2012-2018 (USD Million)
Figure South America Market Size and Growth, 2012-2018 (in Volume)
Table South America CAGR by Revenue and Volume, 2012-2018
6.1.4.2 South America Market by Type
Figure South America Market Size by Type
Figure South America Market Share by Type
6.1.4.3 South America Market by Application
Figure South America Market Size by Application
Figure South America Market Share by Application
6.1.5 Middle East & Africa
6.1.5.1 Middle East & Africa Market, 2012-2018
Figure Middle East & Africa Market Size and Growth, 2012-2018 (USD Million)
Figure Middle East & Africa Market Size and Growth, 2012-2018 (in Volume)
Table Middle East & Africa CAGR by Revenue and Volume, 2012-2018
6.1.5.2 Middle East & Africa Market by Type
Figure Middle East & Africa Market Size by Type
Figure Middle East & Africa Market Share by Type
6.1.5.3 Middle East & Africa Market by Application
Figure Middle East & Africa Market Size by Application
Figure Middle East & Africa Market Share by Application
6.2 Market Forecast
6.2.1 Asia-Pacific Market Forecast, 2020-2025
Figure Asia-Pacific Market Estimates and Forecasts, 2020-2025 (USD Million)
Figure Asia-Pacific Market Estimates and Forecasts, 2020-2025 (in Volume)
Table Asia-Pacific CAGR by Revenue and Volume, 2020-2025
6.2.2 North America Market Forecast, 2020-2025
Figure North America Market Estimates and Forecasts, 2020-2025 (USD Million)
Figure North America Market Estimates and Forecasts, 2020-2025 (in Volume)
Table North America CAGR by Revenue and Volume, 2020-2025
6.2.3 Europe Market Forecast, 2020-2025
Figure Europe Market Estimates and Forecasts, 2020-2025 (USD Million)
Figure Europe Market Estimates and Forecasts, 2020-2025 (in Volume)
Table Europe CAGR by Revenue and Volume, 2020-2025
6.2.4 South America Market Forecast, 2020-2025
Figure South America Market Estimates and Forecasts, 2020-2025 (USD Million)
Figure South America Market Estimates and Forecasts, 2020-2025 (in Volume)
Table South America CAGR by Revenue and Volume, 2020-2025
6.2.5 Middle East & Africa Market Forecast, 2020-2025
Figure Middle East & Africa Market Estimates and Forecasts, 2020-2025 (USD Million)
Figure Middle East & Africa Market Estimates and Forecasts, 2020-2025 (in Volume)
Table Middle East & Africa CAGR by Revenue and Volume, 2020-2025
7 Market Competitive
7.1 Global Market by Vendors
Table Global RNAi for Therapeutic Market by Vendors, 2012-2018 (in Volume)
Table Global RNAi for Therapeutic Market Share by Vendors, 2012-2018 (USD Million)
Table Global RNAi for Therapeutic Market Share by Vendors, 2012-2018 (in Volume)
7.2 Market Concentration
Figure RNAi for Therapeutic Market Concentration by Region
7.3 Price & Factors
Table Price Factors List
7.4 Marketing Channel
Figure Marketing Channels Overview
8 Major Vendors
8.1 Alnylam Pharmaceuticals
Table Alnylam Pharmaceuticals Profile List
Table Microecological Modulator Operating Data of Alnylam Pharmaceuticals (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
8.2 Arrowhead
Table Arrowhead Profile List
Table Microecological Modulator Operating Data of Arrowhead (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
8.3 Dicerna Pharmaceuticals
Table Dicerna Pharmaceuticals Profile List
Table Microecological Modulator Operating Data of Dicerna Pharmaceuticals (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
8.4 Mirna Therapeutics
Table Mirna Therapeutics Profile List
Table Microecological Modulator Operating Data of Mirna Therapeutics (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
8.5 Quark Pharmaceuticals
Table Quark Pharmaceuticals Profile List
Table Microecological Modulator Operating Data of Quark Pharmaceuticals (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
8.6 RXi Pharmaceuticals
Table RXi Pharmaceuticals Profile List
Table Microecological Modulator Operating Data of RXi Pharmaceuticals (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
8.7 miRagen Therapeutics
Table miRagen Therapeutics Profile List
Table Microecological Modulator Operating Data of miRagen Therapeutics (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
8.8 Gradalis
Table Gradalis Profile List
Table Microecological Modulator Operating Data of Gradalis (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
8.9 Sirnaomics
Table Sirnaomics Profile List
Table Microecological Modulator Operating Data of Sirnaomics (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
9 Conclusion
Table Product Specifications of RNAi for Therapeutic
Table Products Segment of RNAi for Therapeutic
Table Global RNAi for Therapeutic Market by Type, 2011-2022 (USD Million)
Table siRNA Overview
Table miRNA Overview
Table shRNA Overview
Table Application Segment of RNAi for Therapeutic
Table Global RNAi for Therapeutic Market by Application, 2011-2022 (USD Million)
Table Cancer Overview
Table Cardiovascular Overview
Table HBV Overview
Table Others Overview
Table Global RNAi for Therapeutic Market by Region, 2011-2022 (USD Million)
Table Cost of RNAi for Therapeutic
Table Market Dynamics
Table Policy of RNAi for Therapeutic
Table GDP of Major Countries
Table Technology of RNAi for Therapeutic
Table Market Entry of RNAi for Therapeutic
Table siRNA CAGR by Revenue and Volume, 2012-2018
Table miRNA CAGR by Revenue and Volume, 2012-2018
Table shRNA CAGR by Revenue and Volume, 2012-2018
Table siRNA CAGR by Revenue and Volume, 2012-2024
Table miRNA CAGR by Revenue and Volume, 2012-2024
Table shRNA CAGR by Revenue and Volume, 2012-2024
Table Cancer CAGR by Revenue and Volume, 2012-2018
Table Cardiovascular CAGR by Revenue and Volume, 2012-2018
Table HBV CAGR by Revenue and Volume, 2012-2018
Table Others CAGR by Revenue and Volume, 2012-2018
Table Cancer CAGR by Revenue and Volume, 2020-2025
Table Cardiovascular CAGR by Revenue and Volume, 2020-2025
Table HBV CAGR by Revenue and Volume, 2020-2025
Table Others CAGR by Revenue and Volume, 2020-2025
Table Asia-Pacific CAGR by Revenue and Volume, 2012-2018
Table North America CAGR by Revenue and Volume, 2012-2018
Table Europe CAGR by Revenue and Volume, 2012-2018
Table South America CAGR by Revenue and Volume, 2012-2018
Table Middle East & Africa CAGR by Revenue and Volume, 2012-2018
Table Asia-Pacific CAGR by Revenue and Volume, 2020-2025
Table North America CAGR by Revenue and Volume, 2020-2025
Table Europe CAGR by Revenue and Volume, 2020-2025
Table South America CAGR by Revenue and Volume, 2020-2025
Table Middle East & Africa CAGR by Revenue and Volume, 2020-2025
Table Global RNAi for Therapeutic Market by Vendors, 2012-2018 (in Volume)
Table Global RNAi for Therapeutic Market Share by Vendors, 2012-2018 (USD Million)
Table Global RNAi for Therapeutic Market Share by Vendors, 2012-2018 (in Volume)
Table Price Factors List
Table Alnylam Pharmaceuticals Profile List
Table Microecological Modulator Operating Data of Alnylam Pharmaceuticals (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Arrowhead Profile List
Table Microecological Modulator Operating Data of Arrowhead (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Dicerna Pharmaceuticals Profile List
Table Microecological Modulator Operating Data of Dicerna Pharmaceuticals (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Mirna Therapeutics Profile List
Table Microecological Modulator Operating Data of Mirna Therapeutics (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Quark Pharmaceuticals Profile List
Table Microecological Modulator Operating Data of Quark Pharmaceuticals (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table RXi Pharmaceuticals Profile List
Table Microecological Modulator Operating Data of RXi Pharmaceuticals (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table miRagen Therapeutics Profile List
Table Microecological Modulator Operating Data of miRagen Therapeutics (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Gradalis Profile List
Table Microecological Modulator Operating Data of Gradalis (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Sirnaomics Profile List
Table Microecological Modulator Operating Data of Sirnaomics (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Similar Reports
This new 68-country report from LeadingMarketResearch.com is available by region, country, market segment, section, or individual test.
The report is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities in the global blood banking market during the next five years, and assist industry executives in developing effective business, new ...
- Publish Date: March 2, 2020
- $0
Hearing aids in the form of analog units have been traditionally present and used in India. Digital hearing units are finding increased growth in acceptability owing to the changing perceptions and growing base of the target consumer group. The Indian market is largely dependent on imports from foreign countries; domestic players in the country are ramping up their manufacturing facilities. The gr...
- Publish Date: March 10, 2011
- $950
The Indian medical devices market is largely dependent on imports from foreign countries. Although domestic players in the country are ramping up their manufacturing facilities, the foreign companies continue to enjoy a superior market share on account of their brand recognition, reliability, and technological superiority. The growing target base of consumers will boost sales and the market is exp...
- Publish Date: July 18, 2011
- $950
